vai al contenuto della pagina vai al menu di navigazione
 

GIST e sarcomi

Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)
BMC Cancer. 2014 Sep 20;14:685.
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours.
Oncol Lett. 2014 Oct;8(4):1793-1799.
Folate-related polymorphisms in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome
Eur J Hum Genet. 2014 Sep 17.
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations
Genet Med. 2014 Sep 4.
Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways.
Cancer Med. 2014 Aug 28.
Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumors
Clin Sarcoma Res. 2014 Aug 9;4:9.
Liquid biopsy in gastrointestinal stromal tumors: a novel approach
J Transl Med. 2014 Aug 14;12:210.
Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma
World J Gastroenterol. 2014 Jun 14;20(22):7049-54.
Activity of sunitinib in extraskeletal myxoid chondrosarcoma.
Eur J Cancer. 2014 Jun;50(9):1657-64.
Novel clinically relevant genes in GIST--letter
Clin Cancer Res. 2014 Apr 1;20(7):2014.
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST
Eur J Hum Genet. 2014 Jan;22(1):32-9.
Insulin-like Growth Factor (IGF) system and gastrointestinal stromal tumours (GIST): present and future
Histol Histopathol. 2014 Feb;29(2):167-75.
Archivio anno 2013
Archivio anno 2012
Archivio anno 2011
Archivio anno 2010
Archivio anno 2009
Archivio anno 2008
Archivio anno 2007